AGILENT TECHNOLOGIES, INC. (A) Spending and interest coverage
- R&D / revenue · 12 months: Value 6.58%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-31..
- Stock-based compensation / revenue · 12 months: Value 1.78%; Formula and calculation Share-based compensation / revenue. Period ending 2026-07-31..
- Interest coverage · 12 months: Value 15.46×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 6.58% | Research and development expense / revenue. Period ending 2026-07-31. $485.00M ÷ $7.37B × 100 ≈ 6.58% |
| Stock-based compensation / revenue · 12 months | 1.78% | Share-based compensation / revenue. Period ending 2026-07-31. $131.00M ÷ $7.37B × 100 ≈ 1.78% |
| Interest coverage · 12 months | 15.46× | Operating income ÷ reported interest expense. $1.64B ÷ $106.00M ≈ 15.46× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 485.00M USD | Research and Development Expense |
| Revenue | 7.37B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 131.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 1.64B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 106.00M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $485.00M | $7.37B | $131.00M | $1.64B | $106.00M | 6.58% | 1.78% | 15.46× | Reported |
| 2026-04-30 | $473.00M | $7.23B | $131.00M | $1.55B | $105.00M | 6.54% | 1.81% | 14.81× | Reported |
| 2026-01-31 | $459.00M | $7.07B | $129.00M | $1.46B | $109.00M | 6.50% | 1.83% | 13.36× | Reported |
| 2025-10-31 | $455.00M | $6.95B | $128.00M | $1.48B | $112.00M | 6.55% | 1.84% | 13.21× | Reported |
| 2025-07-31 | $447.00M | $6.79B | $128.00M | $1.44B | $117.00M | 6.59% | 1.89% | 12.34× | Reported |
| 2025-04-30 | $463.00M | $6.63B | $124.00M | $1.42B | $111.00M | 6.99% | 1.87% | 12.77× | Reported |
| 2025-01-31 | $464.00M | $6.53B | $125.00M | $1.48B | $102.00M | 7.10% | 1.91% | 14.51× | Reported |
| 2024-10-31 | $479.00M | $6.51B | $129.00M | $1.49B | $96.00M | 7.36% | 1.98% | 15.50× | Reported |
| 2024-07-31 | $482.00M | $6.50B | $117.00M | $1.49B | $86.00M | 7.42% | 1.80% | 17.30× | Reported |
| 2024-04-30 | $473.00M | $6.59B | $118.00M | $1.29B | $88.00M | 7.18% | 1.79% | 14.64× | Reported |
| 2024-01-31 | $486.00M | $6.74B | $111.00M | $1.31B | $92.00M | 7.22% | 1.65% | 14.22× | Reported |
| 2023-10-31 | $481.00M | $6.83B | $111.00M | $1.35B | $95.00M | 7.04% | 1.62% | 14.21× | Reported |
| 2023-07-31 | $486.00M | $6.99B | $123.00M | $1.41B | $96.00M | 6.95% | 1.76% | 14.72× | Reported |
| 2023-04-30 | $484.00M | $7.04B | $122.00M | $1.69B | $91.00M | 6.88% | 1.73% | 18.58× | Reported |
| 2023-01-31 | $473.00M | $6.93B | $125.00M | $1.67B | $88.00M | 6.83% | 1.80% | 18.95× | Reported |
| 2022-10-31 | $467.00M | $6.85B | $125.00M | $1.62B | $84.00M | 6.82% | 1.83% | 19.26× | Reported |
| 2022-07-31 | $464.00M | $6.66B | $121.00M | $1.54B | $82.00M | 6.97% | 1.82% | 18.80× | Reported |
| 2022-04-30 | $461.00M | $6.53B | $115.00M | $1.47B | $84.00M | 7.06% | 1.76% | 17.46× | Reported |
| 2022-01-31 | $455.00M | $6.45B | $114.00M | $1.40B | $83.00M | 7.06% | 1.77% | 16.81× | Reported |
| 2021-10-31 | $441.00M | $6.32B | $110.00M | $1.35B | $81.00M | 6.98% | 1.74% | 16.63× | Reported |
| 2021-07-31 | $427.00M | $6.14B | $108.00M | $1.25B | $79.00M | 6.95% | 1.76% | 15.84× | Reported |
| 2021-04-30 | $406.00M | $5.82B | $105.00M | $1.15B | $77.00M | 6.98% | 1.81% | 14.87× | Reported |
| 2021-01-31 | $494.00M | $5.53B | $96.00M | $959.00M | $77.00M | 8.93% | 1.74% | 12.45× | Reported |
| 2020-10-31 | $495.00M | $5.34B | $83.00M | $846.00M | $78.00M | 9.27% | 1.55% | 10.85× | Reported |
| 2020-07-31 | $495.00M | $5.22B | $78.00M | $797.00M | $80.00M | 9.48% | 1.49% | 9.96× | Reported |
| 2020-04-30 | $504.00M | $5.24B | $76.00M | $792.00M | $79.00M | 9.63% | 1.45% | 10.03× | Reported |
| 2020-01-31 | $406.00M | $5.24B | $75.00M | $906.00M | $76.00M | 7.75% | 1.43% | 11.92× | Reported |
| 2019-10-31 | $404.00M | $5.16B | $72.00M | $941.00M | $74.00M | 7.82% | 1.39% | 12.72× | Reported |
| 2019-07-31 | $404.00M | $5.09B | $71.00M | $959.00M | $71.00M | 7.94% | 1.39% | 13.51× | Reported |
| 2019-04-30 | $400.00M | $5.02B | $67.00M | $955.00M | $71.00M | 7.97% | 1.33% | 13.45× | Reported |
| 2019-01-31 | $393.00M | $4.99B | $63.00M | $949.00M | $73.00M | 7.88% | 1.26% | 13.00× | Reported |
| 2018-10-31 | $385.00M | $4.91B | $70.00M | $928.00M | $75.00M | 7.83% | 1.42% | 12.37× | Reported |
| 2018-07-31 | $370.00M | $4.81B | $68.00M | $912.00M | $77.00M | 7.69% | 1.41% | 11.84× | Reported |
| 2018-04-30 | $360.00M | $4.72B | $68.00M | $888.00M | $78.00M | 7.63% | 1.44% | 11.38× | Reported |
| 2018-01-31 | $353.00M | $4.62B | $71.00M | $874.00M | $79.00M | 7.65% | 1.54% | 11.06× | Reported |
| 2017-10-31 | $339.00M | $4.47B | $60.00M | $841.00M | $79.00M | 7.58% | 1.34% | 10.65× | Reported |
| 2017-07-31 | $334.00M | $4.39B | $59.00M | $791.00M | $78.00M | 7.60% | 1.34% | 10.14× | Reported |
| 2017-04-30 | $333.00M | $4.32B | $57.00M | $736.00M | $76.00M | 7.70% | 1.32% | 9.68× | Reported |
| 2017-01-31 | $330.00M | $4.24B | $55.00M | $666.00M | $74.00M | 7.78% | 1.30% | 9.00× | Reported |
| 2016-10-31 | $329.00M | $4.20B | $58.00M | $615.00M | $72.00M | 7.83% | 1.38% | 8.54× | Reported |
| 2016-07-31 | $327.00M | $4.13B | $58.00M | $588.00M | $69.00M | 7.93% | 1.41% | 8.52× | Reported |
| 2016-04-30 | $320.00M | $4.10B | $57.00M | $586.00M | $69.00M | 7.81% | 1.39% | 8.49× | Reported |
| 2016-01-31 | $320.00M | $4.04B | $55.00M | $562.00M | $68.00M | 7.92% | 1.36% | 8.26× | Reported |
| 2015-10-31 | $330.00M | $4.04B | $54.00M | $522.00M | $66.00M | 8.17% | 1.34% | 7.91× | Reported |
| 2015-07-31 | $706.00M | $6.98B | $62.00M | $848.00M | $76.00M | 10.12% | 0.89% | 11.16× | Reported |
| 2015-04-30 | $713.00M | $6.97B | $71.00M | $835.00M | $87.00M | 10.22% | 1.02% | 9.60× | Reported |
| 2015-01-31 | $719.00M | $7.00B | $82.00M | $822.00M | $100.00M | 10.27% | 1.17% | 8.22× | Reported |
| 2014-10-31 | $719.00M | $6.98B | $96.00M | $831.00M | $113.00M | 10.30% | 1.38% | 7.35× | Reported |
| 2014-07-31 | $703.00M | $6.89B | $96.00M | $942.00M | $117.00M | 10.20% | 1.39% | 8.05× | Reported |
| 2014-04-30 | $697.00M | $6.78B | $94.00M | $949.00M | $116.00M | 10.28% | 1.39% | 8.18× | Reported |
| 2014-01-31 | $702.00M | $6.78B | $90.00M | $952.00M | $111.00M | 10.35% | 1.33% | 8.58× | Reported |
| 2013-10-31 | $704.00M | $6.78B | $85.00M | $951.00M | $107.00M | 10.38% | 1.25% | 8.89× | Reported |
| 2013-07-31 | $709.00M | $6.83B | $81.00M | $944.00M | $103.00M | 10.38% | 1.19% | 9.17× | Reported |
| 2013-04-30 | $700.00M | $6.90B | $80.00M | $978.00M | $100.00M | 10.14% | 1.16% | 9.78× | Reported |
| 2013-01-31 | $685.00M | $6.90B | $78.00M | $1.06B | $100.00M | 9.92% | 1.13% | 10.65× | Reported |
| 2012-10-31 | $668.00M | $6.86B | $74.00M | $1.12B | $101.00M | 9.74% | 1.08% | 11.08× | Reported |
| 2012-07-31 | $653.00M | $6.82B | $73.00M | $1.15B | $98.00M | 9.58% | 1.07% | 11.78× | Reported |
| 2012-04-30 | $653.00M | $6.79B | $71.00M | $1.17B | $94.00M | 9.62% | 1.05% | 12.39× | Reported |
| 2012-01-31 | $652.00M | $6.73B | $71.00M | $1.13B | $89.00M | 9.69% | 1.05% | 12.71× | Reported |
| 2011-10-31 | $649.00M | $6.62B | $72.00M | $1.07B | $86.00M | 9.81% | 1.09% | 12.45× | Reported |
| 2011-07-31 | $645.00M | $6.46B | $73.00M | $961.00M | $90.00M | 9.98% | 1.13% | 10.68× | Reported |
| 2011-04-30 | $637.00M | $6.16B | $72.00M | $795.00M | $94.00M | 10.35% | 1.17% | 8.46× | Reported |
| 2011-01-31 | $622.00M | $5.75B | $69.00M | $683.00M | $96.00M | 10.82% | 1.20% | 7.11× | Reported |
| 2010-10-31 | $612.00M | $5.44B | $66.00M | $566.00M | $96.00M | 11.24% | 1.21% | 5.90× | Reported |
| 2010-07-31 | $603.00M | $5.04B | $66.00M | $434.00M | (m) | 11.98% | 1.31% | (m) | (m) |
| 2010-04-30 | $602.00M | $4.71B | $70.00M | $318.00M | (m) | 12.79% | 1.49% | (m) | (m) |
| 2010-01-31 | $622.00M | $4.53B | $75.00M | $117.00M | (m) | 13.74% | 1.66% | (m) | (m) |
| 2009-10-31 | $642.00M | $4.48B | $71.00M | $47.00M | (m) | 14.33% | 1.58% | (m) | (m) |
| 2009-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-04-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-10-31 | $704.00M | $5.77B | $82.00M | $795.00M | (m) | 12.19% | 1.42% | (m) | (m) |
| 2008-07-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-10-31 | $685.00M | $5.42B | $139.00M | $584.00M | (m) | 12.64% | 2.56% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |